The second FeNO in asthma module has now been released

What is FeNO? 

FeNO (Fractional exhaled Nitric Oxide), is a test for measuring the amount of Nitric Oxide in the exhaled breath of patients. The results of the test can help with the diagnosis of asthma, by showing the level of inflammation in the lungs. A patient’s FeNO level helps improve the accuracy of asthma diagnosis and helps indicate which medications will work best for them.

About the new elearning module

The new FeNO module (Module 2) focuses on the interpretation of FeNO, providing an enhanced description of what FeNO is and how it can be used in the diagnosis of asthma, with case examples covering a spectrum of clinical scenarios.

An existing, introductory module (Module 1) aims to improve the learner’s understanding of FeNO, how the test is performed and appropriate language to use when talking about FeNO with patients.

Access the elearning

You can read more about the FeNO elearning modules, including how to access them, by visiting the programme page.

If you wish to leave feedback on this elearning modules, please complete the evaluation survey. 

More information

Healthcare professionals who are interested in the FeNO testing can learn more about the two FeNO in Asthma modules from FeNO Clinical Lead at the next virtual FeNO Learning Collaborative on Tuesday 15 March. Hosted by Wessex AHSN, read about the event and register for a place now.

Access the FeNO deployment toolkit. 

For further details on the AAC FeNO programme, visit the NHS England website